BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28508971)

  • 1. Short-term outcome and quality of life in kidney transplant recipient with monoclonal gammopathy.
    Yanishi M; Tsukaguchi H; Yoshida T; Taniguchi H; Yoshida K; Mishima T; Komai Y; Yasuda K; Watanabe M; Sugi M; Kinoshita H; Matsuda T
    CEN Case Rep; 2016 Nov; 5(2):168-172. PubMed ID: 28508971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy of undetermined significance coexisting in patients undergoing kidney transplantation does not adversely influence post-graft clinical outcome.
    Clari R; Tarella C; Giraudi R; Torazza MC; Gallo E; Lavacca A; Fop F; Mella A; Dolla C; Biancone L
    Clin Kidney J; 2021 Jan; 14(1):317-324. PubMed ID: 33564434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients.
    Gagnon MF; Cardinal H; Emond JP; Latour M; Lemieux B
    Transplant Direct; 2019 Oct; 5(10):e489. PubMed ID: 31723584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance.
    Goebel TE; Schiltz NK; Woodside KJ; Pillai AC; Caimi PF; Lazarus HM; Koroukian SM; Campagnaro EL
    Clin Transplant; 2015 Sep; 29(9):851-7. PubMed ID: 26194021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance.
    Aslam N; Trautman CL; Sher T
    Transplant Direct; 2021 Aug; 7(8):e723. PubMed ID: 34263021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy.
    Soltero L; Carbajal H; Xu J; McCarthy J; Suki WN; Gaber AO; Adrogué HE
    Clin Transplant; 2012; 26(2):300-4. PubMed ID: 22044717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up monoclonal gammopathy of undetermined significance in kidney transplant.
    Cuéllar-García C; Sevillano Ruiz-Mateos C; Mazuecos Blanca MA; Narvaez Mejia C; Fernandez Valle MC; Martin Reina V; Gonzalez Bernal M; Yera Cobo M; Rodriguez Lopez R; de Cos Hohr C; Garrastazul MP; Marchante I; Paz Coll A; Capote Huelva FJ
    Transplant Proc; 2015; 47(1):78-80. PubMed ID: 25645776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients.
    Babel N; Schwarzmann F; Pruss A; Volk HD; Reinke P
    Transplant Proc; 2004 Nov; 36(9):2679-82. PubMed ID: 15621122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Light Chain Proximal Tubulopathy in a Kidney Allograft.
    Angioi A; Amer H; Fervenza FC; Sethi S
    Am J Kidney Dis; 2016 Sep; 68(3):483-7. PubMed ID: 27321964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.
    Jimenez-Zepeda VH; Heilman RL; Engel RA; Carey EJ; Freeman C; Rakela J; Mulligan DC; Fonseca R; Stewart AK
    Transplantation; 2011 Sep; 92(5):570-4. PubMed ID: 21712755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
    Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort.
    Lee YG; Bang SM; Lee JO; Kim JW; Lee KW; Kim JH; Song JH; Kim TH; Kim KW; Lee JS
    Cancer Res Treat; 2015 Apr; 47(2):215-20. PubMed ID: 25345461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
    Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
    Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies.
    Galioto A; Morando F; Rosi S; Schipilliti M; Fasolato S; Magrin M; Frigo AC; Adami F; Cavallin M; Zanus G; Plebani M; Romano A; Sticca A; Cillo U; Gatta A; Angeli P
    Transpl Int; 2012 Jan; 25(1):25-33. PubMed ID: 21999283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
    Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
    Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
    Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
    Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.